
Zynerba Pharmaceuticals ZYNE
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Zynerba Pharmaceuticals Betriebszyklus 2011-2026 | ZYNE
Betriebszyklus Jährlich Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 14.6 K | - | 182 K | 467 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 182 K | 467 | 65.7 K |
Betriebszyklus anderer Aktien in der Arzneimittelhersteller
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
662 | $ 5.88 | 0.68 % | $ 87.3 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
117 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
653 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
61.7 | $ 2.86 | 1.96 % | $ 1.1 B | ||
|
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
153 | $ 34.57 | -0.36 % | $ 1.27 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
152 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | ||
|
Organogenesis Holdings
ORGO
|
106 | $ 2.51 | 1.01 % | $ 318 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 23.11 | 1.92 % | $ 1.07 B | ||
|
Bausch Health Companies
BHC
|
79.8 | $ 5.23 | -0.29 % | $ 1.94 B | ||
|
Canopy Growth Corporation
CGC
|
230 | $ 1.08 | 3.85 % | $ 116 M | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.57 | 1.76 % | $ 196 M | ||
|
Jupiter Wellness
JUPW
|
132 | - | - | $ 33.6 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
182 | $ 1.19 | -1.65 % | $ 1.48 M | ||
|
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.1 | 1.39 % | $ 105 M | ||
|
Tilray
TLRY
|
222 | $ 5.39 | 3.76 % | $ 3.33 B | ||
|
Evolus
EOLS
|
134 | $ 6.65 | 0.68 % | $ 429 M | ||
|
Emergent BioSolutions
EBS
|
425 | $ 8.45 | 0.24 % | $ 452 M | ||
|
cbdMD
YCBD
|
152 | $ 0.77 | 2.53 % | $ 3.1 M | ||
|
Veru
VERU
|
271 | $ 4.01 | -5.2 % | $ 58.7 M | ||
|
Assertio Holdings
ASRT
|
590 | $ 23.46 | 0.02 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
982 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
239 | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
601 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
2.74 | $ 4.99 | 2.25 % | $ 249 M | ||
|
PLx Pharma
PLXP
|
113 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
221 | $ 16.08 | 1.1 % | $ 18.7 B | ||
|
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
72.5 | $ 0.67 | -3.56 % | $ 24.1 M | ||
|
China Pharma Holdings
CPHI
|
187 | $ 0.82 | -5.55 % | $ 3.52 M | ||
|
TherapeuticsMD
TXMD
|
3.34 K | $ 2.0 | - | $ 23.1 M |